Business
Sangamo Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo,
About this update from Sangamo Therapeutics, Inc.
[{"type":"text","content":" BRISBANE, Calif.--(BUSINESS WIRE)--\nSangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present a corporate overview at the 38th Annual J.P. Morgan Healthcare Conference on Thursday, January 16th at 8:30 a.m. PT in San Francisco.\n\n\nThe presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.\n\n\nAbout Sangamo Therapeutics \n\n\nSangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20200109005263/en/\n\nInvestor Relations – Global\nMcDavid Stilwell\n510-970-6000, x219\[email protected] \n\n\nMedia Inquiries – Global\nAron Feingold\n510-970-6000, x421\[email protected]\n\nSource: Sangamo Therapeutics, Inc.","length":2882,"tagName":"div"}]